688289 圣湘生物
已收盘 08-11 15:00:00
资讯
新帖
简况
圣湘生物最新公告:原持股5%以上股东部分股份拟被司法强制执行
证券之星 · 08-10 18:20
圣湘生物最新公告:原持股5%以上股东部分股份拟被司法强制执行
圣湘生物董秘黄强荣获第十二届金麒麟·金牌董秘荣誉
新浪财经 · 08-10 15:24
圣湘生物董秘黄强荣获第十二届金麒麟·金牌董秘荣誉
圣湘生物获得实用新型专利授权:“检测耗材和检测设备”
证券之星 · 07-31
圣湘生物获得实用新型专利授权:“检测耗材和检测设备”
圣湘生物获得发明专利授权:“裂解保存液、组合产品、试剂盒、核酸样本的制备方法和检测方法”
证券之星 · 07-18
圣湘生物获得发明专利授权:“裂解保存液、组合产品、试剂盒、核酸样本的制备方法和检测方法”
圣湘生物(688289)披露股份回购实施结果公告,7月17日股价下跌3.58%
证券之星 · 07-17
圣湘生物(688289)披露股份回购实施结果公告,7月17日股价下跌3.58%
圣湘生物:完成9998.07万元股份回购 用于员工持股或激励
格隆汇 · 07-17
圣湘生物:完成9998.07万元股份回购 用于员工持股或激励
每周股票复盘:圣湘生物(688289)拟注销445万回购股份
证券之星 · 07-12
每周股票复盘:圣湘生物(688289)拟注销445万回购股份
圣湘生物(688289)披露关于变更部分回购股份用途并注销暨减少注册资本的议案,7月9日股价上涨0.48%
证券之星 · 07-09
圣湘生物(688289)披露关于变更部分回购股份用途并注销暨减少注册资本的议案,7月9日股价上涨0.48%
每周股票复盘:圣湘生物(688289)拟注销445万回购股份
证券之星 · 07-05
每周股票复盘:圣湘生物(688289)拟注销445万回购股份
圣湘生物(688289)披露与专业机构共同投资设立基金暨关联交易进展,6月30日股价下跌2.04%
证券之星 · 06-30
圣湘生物(688289)披露与专业机构共同投资设立基金暨关联交易进展,6月30日股价下跌2.04%
每周股票复盘:圣湘生物(688289)股东陈文义持股降至4.56%
证券之星 · 06-28
每周股票复盘:圣湘生物(688289)股东陈文义持股降至4.56%
圣湘生物(688289)披露以集中竞价交易方式首次回购公司股份的公告,6月26日股价上涨1.8%
证券之星 · 06-26
圣湘生物(688289)披露以集中竞价交易方式首次回购公司股份的公告,6月26日股价上涨1.8%
圣湘生物(688289)披露持股5%以上股东部分股份被司法强制执行的实施结果公告,6月25日股价下跌2.8%
证券之星 · 06-25
圣湘生物(688289)披露持股5%以上股东部分股份被司法强制执行的实施结果公告,6月25日股价下跌2.8%
圣湘生物(688289)披露变更部分回购股份用途并注销暨减少注册资本的公告,6月23日股价上涨2.09%
证券之星 · 06-23
圣湘生物(688289)披露变更部分回购股份用途并注销暨减少注册资本的公告,6月23日股价上涨2.09%
圣湘生物(688289.SH)拟5000万元至1亿元回购股份
智通财经 · 06-23
圣湘生物(688289.SH)拟5000万元至1亿元回购股份
圣湘生物最新公告:肺炎克雷伯菌及KPC基因检测试剂盒获医疗器械注册证
证券之星 · 06-23
圣湘生物最新公告:肺炎克雷伯菌及KPC基因检测试剂盒获医疗器械注册证
股市必读:XD圣湘生(688289)6月22日圣湘生物发布公告,股东减持142.79万股
证券之星 · 06-23
股市必读:XD圣湘生(688289)6月22日圣湘生物发布公告,股东减持142.79万股
圣湘生物(688289)披露持股5%以上股东权益变动触及5%刻度的提示性公告,6月22日股价下跌1.35%
证券之星 · 06-22
圣湘生物(688289)披露持股5%以上股东权益变动触及5%刻度的提示性公告,6月22日股价下跌1.35%
每周股票复盘:圣湘生物(688289)股东陈文义持股被司法强制执行
证券之星 · 06-20
每周股票复盘:圣湘生物(688289)股东陈文义持股被司法强制执行
圣湘生物(688289)披露持股5%以上股东部分股份被司法强制执行的实施结果暨拟被再次司法强制执行的提示性公告,6月18日股价上涨0.99%
证券之星 · 06-18
圣湘生物(688289)披露持股5%以上股东部分股份被司法强制执行的实施结果暨拟被再次司法强制执行的提示性公告,6月18日股价上涨0.99%
加载更多
公司概况
公司名称:
圣湘生物科技股份有限公司
所属行业:
医药制造业
上市日期:
2020-08-28
主营业务:
圣湘生物科技股份有限公司的主营业务是诊断试剂和仪器的研发、生产、销售,以及第三方医学检验服务。公司的主要产品是诊断试剂、诊断仪器、生物类药品、检测服务。公司是国家基因检测技术应用示范中心、感染性疾病及肿瘤基因诊断技术国家地方联合工程研究中心、国家企业技术中心、国家技术创新示范企业、国家级博士后科研工作站单位、国家知识产权示范企业,荣获国家科技进步二等奖、中国专利银奖等60余项国内外重大奖项,承担国家“十三五”“十四五”等重大项目60余项。
发行价格:
50.48
{"stockData":{"symbol":"688289","market":"SH","secType":"STK","nameCN":"圣湘生物","latestPrice":15.62,"timestamp":1786431600000,"preClose":16.06,"halted":0,"volume":5160237,"delay":0,"changeRate":-0.0274,"floatShares":579000000,"shares":579000000,"eps":0.2709,"marketStatus":"已收盘","change":-0.44,"latestTime":"08-11 15:00:00","open":15.95,"high":15.98,"low":15.62,"amount":81475500,"amplitude":0.0224,"askPrice":15.63,"askSize":2,"bidPrice":15.62,"bidSize":376,"shortable":0,"etf":0,"ttmEps":0.2709,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1786498200000},"marketStatusCode":5,"adr":0,"adjPreClose":16.06,"symbolType":"stock_kcb","openAndCloseTimeList":[[1786411800000,1786419000000],[1786424400000,1786431600000]],"highLimit":17.67,"lowLimit":14.45,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":579388006,"isCdr":false,"pbRate":1.26,"roa":"--","peRate":57.659653,"roe":"0.69%","epsLYR":0.34,"committee":0.320287,"marketValue":9050000000,"turnoverRate":0.0089,"status":1,"afterMarket":{"amount":591998,"volume":37900,"close":15.62,"buyVolume":0,"sellVolume":2223,"time":1786433637746,"indexStatus":"已收盘 08-11 15:30:00","preClose":16.06},"floatMarketCap":9050000000},"requestUrl":"/m/hq/s/688289/","defaultTab":"news","newsList":[{"id":"2658101987","title":"圣湘生物最新公告:原持股5%以上股东部分股份拟被司法强制执行","url":"https://stock-news.laohu8.com/highlight/detail?id=2658101987","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658101987?lang=zh_cn&edition=full","pubTime":"2026-08-10 18:20","pubTimestamp":1786357212,"startTime":"0","endTime":"0","summary":"圣湘生物(688289.SH)公告称,公司原持股5%以上股东陈文义所持部分股份拟被司法强制执行。湖南省株洲市中级人民法院拟通过大宗交易或集中竞价方式分批次卖出其持有的公司无限售流通股合计571万股,占公司总股本的0.99%,减持期限不晚于2027年12月30日。本次执行后,陈文义持股数量将由2642.74万股降至2071.74万股,持股比例由4.56%降至3.58%。该事项不会影响公司控制权稳定,不会对日常经营造成影响。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000026170.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658985912","title":"圣湘生物董秘黄强荣获第十二届金麒麟·金牌董秘荣誉","url":"https://stock-news.laohu8.com/highlight/detail?id=2658985912","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658985912?lang=zh_cn&edition=full","pubTime":"2026-08-10 15:24","pubTimestamp":1786346640,"startTime":"0","endTime":"0","summary":"登录新浪财经APP 搜索查看更多考评等级专题:专题:第十二届金麒麟·金牌董秘及优秀证代荣誉榜单揭晓!8月10日,新浪财经第十二届金麒麟金牌董秘榜单正式揭晓。圣湘生物董事会秘书黄强凭借扎实的合规治理能力、成熟的投资者关系运营、长期稳健的资本价值传递表现,荣耀加冕第十二届金麒麟金牌董秘。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/roll/2026-08-10/doc-inimvhfm1300872.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688289","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655388977","title":"圣湘生物获得实用新型专利授权:“检测耗材和检测设备”","url":"https://stock-news.laohu8.com/highlight/detail?id=2655388977","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655388977?lang=zh_cn&edition=full","pubTime":"2026-07-31 03:26","pubTimestamp":1785439583,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示圣湘生物新获得一项实用新型专利授权,专利名为“检测耗材和检测设备”,专利申请号为CN202521291710.4,授权日为2026年7月31日。采用上述的检测耗材,能够防止第一试剂中的强碱性或强腐蚀性物质将隔膜腐蚀的技术问题,提高检测精度和检测效果。今年以来圣湘生物新获得专利授权38个,较去年同期增加了40.74%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073100003999.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652280885","title":"圣湘生物获得发明专利授权:“裂解保存液、组合产品、试剂盒、核酸样本的制备方法和检测方法”","url":"https://stock-news.laohu8.com/highlight/detail?id=2652280885","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652280885?lang=zh_cn&edition=full","pubTime":"2026-07-18 03:24","pubTimestamp":1784316257,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示圣湘生物新获得一项发明专利授权,专利名为“裂解保存液、组合产品、试剂盒、核酸样本的制备方法和检测方法”,专利申请号为CN202411996692.X,授权日为2026年7月17日。采用本申请的制备方法的核酸样本,无需清洗,即可直接进行PCR等检测,操作简单,适用于急诊等场合。今年以来圣湘生物新获得专利授权35个,较去年同期增加了66.67%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071800002437.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652128137","title":"圣湘生物(688289)披露股份回购实施结果公告,7月17日股价下跌3.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652128137","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652128137?lang=zh_cn&edition=full","pubTime":"2026-07-17 22:49","pubTimestamp":1784299751,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘,圣湘生物报收于15.34元,较前一交易日下跌3.58%,最新总市值为88.88亿元。该股当日开盘15.83元,最高15.97元,最低15.24元,成交额达1.37亿元,换手率为1.53%。近日,圣湘生物科技股份有限公司发布《关于股份回购实施结果的公告》。回购股份将用于员工持股计划或股权激励,存放于回购专用证券账户期间不享有相关股东权利。若三年内未使用完毕,将依法注销。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700045257.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652400542","title":"圣湘生物:完成9998.07万元股份回购 用于员工持股或激励","url":"https://stock-news.laohu8.com/highlight/detail?id=2652400542","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652400542?lang=zh_cn&edition=full","pubTime":"2026-07-17 19:25","pubTimestamp":1784287542,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0239","688289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650154601","title":"每周股票复盘:圣湘生物(688289)拟注销445万回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2650154601","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650154601?lang=zh_cn&edition=full","pubTime":"2026-07-12 02:27","pubTimestamp":1783794429,"startTime":"0","endTime":"0","summary":"截至2026年7月10日收盘,圣湘生物报收于14.99元,较上周的15.12元下跌0.86%。本周关注点公司公告汇总:圣湘生物拟注销4,450,202股回购股份,减少注册资本。注销后公司总股本将由579,388,006股变更为574,937,804股,注册资本相应减少。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071200000776.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650058920","title":"圣湘生物(688289)披露关于变更部分回购股份用途并注销暨减少注册资本的议案,7月9日股价上涨0.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2650058920","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650058920?lang=zh_cn&edition=full","pubTime":"2026-07-09 22:30","pubTimestamp":1783607430,"startTime":"0","endTime":"0","summary":"截至2026年7月9日收盘,圣湘生物报收于14.67元,较前一交易日上涨0.48%,最新总市值为85亿元。近日,圣湘生物科技股份有限公司发布2026年第三次临时股东会决议公告。会议审议通过《关于变更部分回购股份用途并注销暨减少注册资本的议案》,该议案为特别决议议案,已获出席股东所持有效表决权的2/3以上通过,并对中小投资者单独计票。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070900042586.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649923856","title":"每周股票复盘:圣湘生物(688289)拟注销445万回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2649923856","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649923856?lang=zh_cn&edition=full","pubTime":"2026-07-05 03:29","pubTimestamp":1783193350,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘,圣湘生物报收于15.12元,较上周的14.12元上涨7.08%。本周,圣湘生物7月2日盘中最高价报15.52元。圣湘生物科技股份有限公司拟将已回购但尚未用于员工持股计划或股权激励的4,450,202股股份予以注销,减少注册资本。本次注销后,公司总股本将由579,388,006股变更为574,937,804股,注册资本相应减少。圣湘生物科技股份有限公司于2026年7月1日披露了截至2026年6月23日前十大股东和前十大无限售条件股东的持股情况,包括股东名称、持股数量及占比。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070500001138.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647534415","title":"圣湘生物(688289)披露与专业机构共同投资设立基金暨关联交易进展,6月30日股价下跌2.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2647534415","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647534415?lang=zh_cn&edition=full","pubTime":"2026-06-30 17:58","pubTimestamp":1782813528,"startTime":"0","endTime":"0","summary":"截至2026年6月30日收盘,圣湘生物报收于14.4元,较前一交易日下跌2.04%,最新总市值为83.43亿元。该股当日开盘14.7元,最高14.73元,最低14.27元,成交额达7158.86万元,换手率为0.86%。圣湘生物科技股份有限公司于近日发布《关于与专业机构共同投资设立基金暨关联交易的进展公告》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026063000033976.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688289","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646313137","title":"每周股票复盘:圣湘生物(688289)股东陈文义持股降至4.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646313137","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646313137?lang=zh_cn&edition=full","pubTime":"2026-06-28 02:24","pubTimestamp":1782584652,"startTime":"0","endTime":"0","summary":"本周关注点股本股东变化:股东陈文义因司法强制执行,持股比例由5.56%降至4.56%。股本股东变化股东增减持6月22日,圣湘生物股东陈文义在2026年3月17日至6月22日期间合计减持142.79万股,占总股本0.2464%,期间股价下跌26.68%,截至6月22日收盘价为13.88元。执行完成后,持股数量由30,397,386股减少至26,427,386股,持股比例由5.25%下降至4.56%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062800000586.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646135549","title":"圣湘生物(688289)披露以集中竞价交易方式首次回购公司股份的公告,6月26日股价上涨1.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646135549","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646135549?lang=zh_cn&edition=full","pubTime":"2026-06-26 17:51","pubTimestamp":1782467489,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘,圣湘生物报收于14.12元,较前一交易日上涨1.8%,最新总市值为81.81亿元。该股当日开盘13.87元,最高14.73元,最低13.79元,成交额达1.3亿元,换手率为1.57%。圣湘生物科技股份有限公司于2026年6月26日披露《关于以集中竞价交易方式首次回购公司股份的公告》。回购股份拟用于员工持股计划或股权激励。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062600033147.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646269876","title":"圣湘生物(688289)披露持股5%以上股东部分股份被司法强制执行的实施结果公告,6月25日股价下跌2.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646269876","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646269876?lang=zh_cn&edition=full","pubTime":"2026-06-25 17:37","pubTimestamp":1782380257,"startTime":"0","endTime":"0","summary":"截至2026年6月25日收盘,圣湘生物报收于13.87元,较前一交易日下跌2.8%,最新总市值为80.36亿元。该股当日开盘14.16元,最高14.2元,最低13.68元,成交额达7232.53万元,换手率为0.9%。圣湘生物科技股份有限公司于近日发布公告,披露持股5%以上股东陈文义先生因债务履行需求,其所持公司股份被法院依法强制执行。执行完成后,陈文义先生持股由30,397,386股减少至26,427,386股,持股比例由5.25%下降至4.56%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062500032269.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645383270","title":"圣湘生物(688289)披露变更部分回购股份用途并注销暨减少注册资本的公告,6月23日股价上涨2.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645383270","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645383270?lang=zh_cn&edition=full","pubTime":"2026-06-23 22:33","pubTimestamp":1782225196,"startTime":"0","endTime":"0","summary":"截至2026年6月23日收盘,圣湘生物报收于14.17元,较前一交易日上涨2.09%,最新总市值为82.1亿元。近日,圣湘生物科技股份有限公司发布《关于变更部分回购股份用途并注销暨减少注册资本的公告》。公告显示,公司拟将存放于回购专用证券账户中原用于员工持股计划或股权激励的4,450,202股股份予以注销,减少注册资本。本次变更部分回购股份用途并注销不会对公司经营和财务状况产生重大影响,不影响公司上市条件。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062300042706.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688289","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645835254","title":"圣湘生物(688289.SH)拟5000万元至1亿元回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2645835254","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645835254?lang=zh_cn&edition=full","pubTime":"2026-06-23 20:01","pubTimestamp":1782216083,"startTime":"0","endTime":"0","summary":"智通财经APP讯,圣湘生物(688289.SH)发布公告,公司拟5000万元至1亿元回购股份,回购价格不超过22元/股,回购的股份将在未来适宜时机全部用于员工持股计划或股权激励。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1457704.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688289","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645915833","title":"圣湘生物最新公告:肺炎克雷伯菌及KPC基因检测试剂盒获医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2645915833","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645915833?lang=zh_cn&edition=full","pubTime":"2026-06-23 19:20","pubTimestamp":1782213602,"startTime":"0","endTime":"0","summary":"圣湘生物(688289.SH)公告称,公司产品肺炎克雷伯菌及耐碳青霉烯类抗生素基因KPC核酸检测试剂盒(荧光PCR法)近日获国家药监局颁发的《医疗器械注册证》,用于体外定性检测人痰液样本中的肺炎克雷伯菌核酸及KPC耐药基因。该产品系公司第二款“病原+耐药”双覆盖产品,进一步完善了呼吸道感染精准诊断领域布局。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062300036573.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159883","BK1583","BK1574","BK1100","BK0239","09996","688289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645071784","title":"股市必读:XD圣湘生(688289)6月22日圣湘生物发布公告,股东减持142.79万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2645071784","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645071784?lang=zh_cn&edition=full","pubTime":"2026-06-23 01:56","pubTimestamp":1782150971,"startTime":"0","endTime":"0","summary":"股本股东变化:股东陈文义于2026年3月17日至2026年6月22日合计减持142.79万股,占总股本0.2464%,持股比例由5.56%降至5.00%。本次权益变动后,陈文义持有公司股份28,969,486股,占总股本的5.00%,全部处于质押及冻结状态。未来12个月内,陈文义不排除继续减持或增持股份的可能,将依据法院执行情况及法规要求履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062300000899.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645073954","title":"圣湘生物(688289)披露持股5%以上股东权益变动触及5%刻度的提示性公告,6月22日股价下跌1.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645073954","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645073954?lang=zh_cn&edition=full","pubTime":"2026-06-22 22:29","pubTimestamp":1782138556,"startTime":"0","endTime":"0","summary":"截至2026年6月22日收盘,圣湘生物报收于13.88元,较前一交易日下跌1.35%,最新总市值为80.42亿元。近日,圣湘生物科技股份有限公司发布《关于持股5%以上股东权益变动触及5%刻度的提示性公告》。权益变动后,其持股比例由5.56%降至5.00%。本次变动主要由于公司实施资本公积转增股本、股份注销及法院减持所致。权益变动未导致公司控股股东、实际控制人变化,不触及要约收购。相关信息已编制简式权益变动报告书并披露。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062200038966.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688289","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644906523","title":"每周股票复盘:圣湘生物(688289)股东陈文义持股被司法强制执行","url":"https://stock-news.laohu8.com/highlight/detail?id=2644906523","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2644906523?lang=zh_cn&edition=full","pubTime":"2026-06-20 03:09","pubTimestamp":1781896190,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘,圣湘生物报收于14.33元,较上周的14.36元下跌0.21%。公司公告汇总圣湘生物科技股份有限公司于2026年6月19日发布公告,持股5%以上股东陈文义因债务纠纷,其持有的2,519,984股公司股份已被司法强制执行,占公司总股本的0.44%。本次执行后,陈文义持股由32,917,370股减少至30,397,386股,持股比例由5.68%降至5.25%。公司同时收到法院通知,陈文义所持397万股公司股份拟被再次司法强制执行,执行方式包括大宗交易或集中竞价,执行期限不晚于2027年12月30日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062000001873.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688289","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644084265","title":"圣湘生物(688289)披露持股5%以上股东部分股份被司法强制执行的实施结果暨拟被再次司法强制执行的提示性公告,6月18日股价上涨0.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2644084265","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2644084265?lang=zh_cn&edition=full","pubTime":"2026-06-18 22:48","pubTimestamp":1781794097,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘,圣湘生物报收于14.33元,较前一交易日上涨0.99%,最新总市值为83.03亿元。公告显示,持股5%以上股东陈文义因债务纠纷,其持有的2,519,984股公司股份已被司法强制执行,占公司总股本的0.44%。本次执行后,陈文义持股由32,917,370股减少至30,397,386股,持股比例由5.68%降至5.25%。公司同时收到法院通知,陈文义所持397万股公司股份拟被再次司法强制执行,执行方式包括大宗交易或集中竞价,执行期限不晚于2027年12月30日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061800042951.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688289"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1786471191634,"stockEarnings":[{"period":"1week","weight":0.0084},{"period":"1month","weight":0.042},{"period":"3month","weight":-0.1201},{"period":"6month","weight":-0.1859},{"period":"1year","weight":-0.2692},{"period":"ytd","weight":-0.1588}],"compareEarnings":[{"period":"1week","weight":0.0293},{"period":"1month","weight":-0.0155},{"period":"3month","weight":-0.0727},{"period":"6month","weight":-0.0484},{"period":"1year","weight":0.0786},{"period":"ytd","weight":-0.0088}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"圣湘生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"21493人(较上一季度增加7.68%)","perCapita":"26957股","listingDate":"2020-08-28","address":"湖南省长沙市岳麓区高新技术产业开发区麓松路680号","registeredCapital":"57938万元","survey":" 圣湘生物科技股份有限公司的主营业务是诊断试剂和仪器的研发、生产、销售,以及第三方医学检验服务。公司的主要产品是诊断试剂、诊断仪器、生物类药品、检测服务。公司是国家基因检测技术应用示范中心、感染性疾病及肿瘤基因诊断技术国家地方联合工程研究中心、国家企业技术中心、国家技术创新示范企业、国家级博士后科研工作站单位、国家知识产权示范企业,荣获国家科技进步二等奖、中国专利银奖等60余项国内外重大奖项,承担国家“十三五”“十四五”等重大项目60余项。","listedPrice":50.48},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"圣湘生物(688289)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供圣湘生物(688289)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"圣湘生物,688289,圣湘生物股票,圣湘生物股票老虎,圣湘生物股票老虎国际,圣湘生物行情,圣湘生物股票行情,圣湘生物股价,圣湘生物股市,圣湘生物股票价格,圣湘生物股票交易,圣湘生物股票购买,圣湘生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"圣湘生物(688289)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供圣湘生物(688289)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}